Drug Type Monoclonal antibody |
Synonyms- |
Target |
Mechanism BTN2A1 stimulants(Butyrophilin subfamily 2 member A1 stimulants) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization ![]() |
Active Organization- |
Inactive Organization ![]() |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Solid tumor | Preclinical | FR | Imcheck Therapeutics SASStartup | 23 Jul 2020 |
Hematologic Neoplasms | Preclinical | FR | Imcheck Therapeutics SASStartup | 20 Jun 2020 |